Welcome to the home of the DeVos Cardiovascular Research Program, a joint effort between Van Andel Institute and Spectrum Health. Using an interdisciplinary and translational approach, we investigate the heart’s potential to heal itself in order to develop the next generation of cardiac therapies. We have four main focus areas: cell engineering; cell source identification; multi-center patient treatment and clinical trials; and scientific training and career development for future scientists including interns, fellows and graduate students.
DeVos Cardiovascular Research Program
Basic Science
Our basic science program investigates and develops new strategies to regenerate heart muscle, an endeavor important to all types of heart failure.
Clinical Trials
Our clinical group plans trials in late-stage heart failure patients with the goal of identifying and optimizing patient populations for novel therapy.
Publications
Curious about our published work?
Visit our publications page to learn more.
LEARN MORE ABOUT OUR WORK
News
6 Nov. 2019 New technique lays foundation for regenerative cardiac therapies
10 Oct. 2019 Decreasing inflammation after a heart attack may reduce damage
14 March 2019 Seeing a world of possibility in a single cell
VAI Voice
6 March 2018 Meet the scientist behind the science: Dr. Stefan Jovinge
VAI Voice
28 Feb. 2018 Keeping the beat: How to heal the human heart
VAI Voice
29 Sept. 2017 Fixing failing hearts
VAI Voice
14 Feb. 2017 The search is on for ways to mend hearts before they break
VAI Voice
29 Sept. 2016 World Heart Day 2016: Four of the coolest things happening in heart disease research
VAI Voice
12 Jan. 2016 Dr. Stefan Jovinge accepts Stanford University School of Medicine consulting professorship
6 August 2015 Helping the heart heal itself
Spectrum Health HealthBeat
22 June 2015 Can the heart heal itself? Game-changing study by Michigan scientist may lead the way
MLive
year in cardiology: acute coronary syndromes: The year in cardiology 2019
academic.oup.com
The management of acute coronary syndromes (ACS) has made enormous progress over the last five decades due to the introduction of defibrillation, beta blockers,
Dr. Stefan Jovinge is senior author on a study featured on the Dec. 6 cover of Circulation Research! Dr. Jovinge's team devised a new technique that could lead to regenerative cardiac therapies. Read more: bit.ly/2RkelK5@CircRes December Issue is out! ow.ly/oTer30pZ28q ![]()
![]()
About the cover: Mitotic #Cardiomyocytes detected by #MolecularBeacons technology.